ABCB4 and breast angiosarcoma: Here we present novel gene therapy transgene construct elements using vectors with BA-inducible promoters that function with physiological transgene regulation providing potential as a therapeutic approach to cholestatic diseases with BA alterations, such as PFIC2 and PFIC3.